REG - QinetiQ Group plc - Transaction in Own Shares

QinetiqAnnouncement

Tue 10:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260505:nRSE0481Da&default-theme=true

RNS Number : 0481D  QinetiQ Group plc  05 May 2026

QinetiQ Group plc

Transaction in own shares

QinetiQ Group plc (the Company) announces that in the period 27 April 2026 to
1 May 2026 it purchased in aggregate 671,000 ordinary shares of 1 pence each
(Shares) for cancellation through Deutsche Bank AG, London Branch (trading for
these purposes as Deutsche Numis), in accordance with the authority granted by
shareholders at the Annual General Meeting of the Company held on 17 July
2025, and pursuant to the latest tranche of its existing share buyback
programme announced on 25 March 2026. Full details are set out below:

 

 Date           Venue                  Weighted average price paid per share (GBp)  Aggregate number of shares purchased  Lowest price paid per share (GBp)  Highest price paid per share (GBp)
 27 April 2026  London Stock Exchange  450.8068                                     80,000                                448.30                             453.40
                Chi-X                  450.7688                                     20,000                                448.80                             453.00

                (CXE)
                BATS                   450.8182                                     32,000                                448.40                             452.90

                (BXE)
 28 April 2026  London Stock Exchange  442.8604                                     80,000                                437.60                             449.60
                Chi-X                  442.4464                                     20,000                                438.10                             448.80

                (CXE)
                BATS                   442.1535                                     34,000                                437.50                             449.20

                (BXE)
 29 April 2026  London Stock Exchange  441.11                                       80,000                                437.60                             449.60
                Chi-X                  440.43                                       20,000                                438.10                             448.80

                (CXE)
                BATS                   440.12                                       35,000                                437.50                             449.20

                (BXE)
 30 April 2026  London Stock Exchange  439.39                                       80,000                                433.00                             444.70
                Chi-X                  441.12                                       20,000                                436.00                             444.80

                (CXE)
                BATS                   441.18                                       35,000                                436.00                             444.70

                (BXE)
 1 May 2026     London Stock Exchange  441.83                                       80,000                                440.50                             443.10
                Chi-X                  441.81                                       20,000                                440.50                             443.00

                (CXE)
                BATS                   441.86                                       35,000                                440.70                             442.90

                (BXE)

 

All shares purchased by the Company will be cancelled.

Following settlement of the above transactions, the Company's total number of
ordinary shares in issue, and its total voting rights, will be 522,080,971
ordinary shares. This figure may be used by shareholders as the denominator
for the calculations by which they can determine if they are required to
notify their interest, or a change to their interest, in the Company under the
Financial Conduct Authority's Disclosure and Transparency Rules. The Company
does not hold any ordinary shares in treasury.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014, as amended,
a full breakdown of the individual trades made by Deutsche Numis on behalf of
the Company is available via the link below.

http://www.rns-pdf.londonstockexchange.com/rns/0481D_1-2026-5-5.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/0481D_1-2026-5-5.pdf)

 

This announcement will also be available on QinetiQ Group plc's website at:
https://www.qinetiq.com/en/investors (https://www.qinetiq.com/en/investors) .

Enquiries to:

 Andrew Carter, Group Director Investor Relations:  +44 (0) 7392 289116
 Stephanie Mann, Group Head of Media Relations:     +44 (0) 7770 720268
 James Field, Company Secretary:                    +44 (0) 7841 662957

 

LEI: 213800S8OBDOZMCMUW34

This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSAKPBQFBKKDPK



            Copyright 2019 Regulatory News Service, all rights reserved